Apyx Medical Corporation · NASDAQ (us_market)
Healthcare · Medical Devices · United States
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2026-02-02$4.40 RISE2026-05-05$2.79 PEAK2026-05-14$4.36 101d | -36.6% 92d | Missed | Missed | — | — | +56.3% 9d | Missed |
DROP2026-02-02$4.40 RISE2026-03-06$3.12 PEAK2026-05-14$4.36 101d | -29.1% 32d | Missed | Missed | — | — | +39.7% 69d | Missed |
DROP2025-11-12$4.33 RISE2025-12-30$3.44 PEAK2026-02-02$4.40 82d | -20.6% 48d | Missed | Missed | — | — | +27.9% 34d | Missed |
DROP2025-11-12$4.33 RISE2025-12-26$3.44 PEAK2026-02-02$4.40 82d | -20.6% 44d | Missed | Missed | — | — | +27.9% 38d | Missed |
DROP2025-07-07$2.58 RISE2025-09-03$1.90 PEAK2025-11-12$4.33 128d | -26.4% 58d | Missed | Missed | — | — | +127.9% 70d | Missed |
DROP2025-07-07$2.58 RISE2025-08-01$1.75 PEAK2025-10-14$3.40 99d | -32.2% 25d | Missed | Missed | — | — | +94.3% 74d | Missed |
DROP2024-12-02$1.90 RISE2025-04-08$0.87 PEAK2025-07-07$2.58 217d | -54.1% 127d | Missed | Missed | — | — | +195.9% 90d | Missed |
DROP2024-06-17$1.47 RISE2024-10-24$1.10 PEAK2024-12-02$1.90 168d | -25.2% 129d | Missed | Missed | — | — | +72.7% 39d | Missed |
DROP2024-06-03$1.66 RISE2024-09-18$1.05 PEAK2024-12-02$1.90 182d | -36.7% 107d | Missed | Missed | — | — | +81.0% 75d | Missed |
DROP2024-06-03$1.66 RISE2024-08-07$1.01 PEAK2024-08-15$1.38 73d | -39.2% 65d | Missed | Missed | — | — | +36.6% 8d | Missed |
DROP2023-11-28$2.97 RISE2024-03-22$1.25 PEAK2024-05-09$1.66 163d | -57.9% 115d | Missed | Missed | — | — | +32.8% 48d | Missed |
DROP2023-09-07$4.50 RISE2024-01-17$1.93 PEAK2024-02-12$2.71 158d | -57.1% 132d | Missed | Missed | — | — | +40.4% 26d | Missed |
DROP2023-07-17$6.20 RISE2023-11-15$1.49 PEAK2023-11-28$2.97 134d | -75.9% 121d | Missed | Missed | — | — | +99.3% 13d | Missed |
DROP2023-06-28$7.59 RISE2023-08-10$4.21 PEAK2023-08-11$5.05 44d | -44.6% 43d | Missed | Missed | — | — | +20.1% 1d | Missed |
DROP2022-11-07$5.00 RISE2023-03-20$2.51 PEAK2023-06-06$7.00 211d | -49.8% 133d | Missed | Missed | — | — | +178.9% 78d | Missed |
1–15 / 24 1 / 2 | |||||||
Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical" or the "Company"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), will return to Miami Swim Week with its Body by Apyx showcase, an immersive runway experience featuring real patient transformations.
Babcock & Wilcox delivers energy and emissions control solutions to industrial and utility clients worldwide.
Babcock & Wilcox delivers energy and emissions control solutions to industrial and utility clients worldwide.
Oceaneering International delivers subsea robotics, engineered products, and digital solutions to global energy and defense clients.
Oceaneering International delivers subsea robotics, engineered products, and digital solutions to global energy and defense clients.
EZCORP operates a broad network of pawn stores and digital platforms, serving consumers seeking short-term credit and value-priced goods.
EZCORP operates a broad network of pawn stores and digital platforms, serving consumers seeking short-term credit and value-priced goods.
Satellogic delivers real-time Earth observation data and analytics, serving commercial and government clients across multiple industries.
Satellogic delivers real-time Earth observation data and analytics, serving commercial and government clients across multiple industries.
Published data demonstrates visible reduction in dimpling and progressive tissue remodeling through a single-session approachCLEARWATER, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics products marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced the publication of new clinical data in Aesthetic Surgery Journal Open Forum highlighting a promising approach to
In this study, 22 patients received a single treatment session combining these modalities to address both the structural and surface level causes of cellulite and skin laxity. Results showed progressive improvement over
Analysis showed that liposuction followed by helium plasma RF was associated with higher patient-reported satisfaction with abdominal appearance, lower abdominoplasty and revision rates, and comparable complication rates versus conventional liposuction aloneCLEARWATER, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today a
The study evaluated patient-reported outcomes following liposuction with and without helium plasma radiofrequency (Renuvion).The results demonstrate that adding Renuvion to liposuction resulted in statistically
Addition of the power liposuction capability as a second advanced liposuction modality is expected to drive even greater market demand for AYONCLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics products marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced it received expanded 510(k) clearance from the U.S. Food and Drug Administration (the “FDA”) for
Apyx Medical Corporation received expanded 510 clearance from the U.S. Food and Drug Administration for the AYON Body Contouring System to include power liposuction, an advanced form of liposuction...
As you might know, Apyx Medical Corporation ( NASDAQ:APYX ) just kicked off its latest first-quarter results with some...
As you might know, Apyx Medical Corporation ( NASDAQ:APYX ) just kicked off its latest first-quarter results with some...
Apyx Medical Inc: Apyx Medical Corporation receives expanded FDA 510 clearance adding power liposuction capability to Ayon Body Contouring System Apyx Medical Inc - receives expanded FDA 510...
Charles Goodwin: Thank you, Jeremy, and thank you all for joining us today. This growth was driven by a 36% increase in sales of our Surgical Aesthetics products to $10.7 million for the first quarter, which was primarily attributable to the continued strong sales ramp of our AYON body contouring system in the U.S., demand for single-use handpieces worldwide and increase in Renuvion generator sales internationally. This represents our second full quarter of AYON sales following its full commercial launch in September 2025.
Charles Goodwin: Thank you, Jeremy, and thank you all for joining us today. This growth was driven by a 36% increase in sales of our Surgical Aesthetics products to $10.7 million for the first quarter, which was primarily attributable to the continued strong sales ramp of our AYON body contouring system in the U.S., demand for single-use handpieces worldwide and increase in Renuvion generator sales internationally. This represents our second full quarter of AYON sales following its full commercial launch in September 2025.
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| APYX | +30.56% | +21.80% | +14.14% | +156.09% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | +27.59% | +27.51% | +17.59% | +143.40% |
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| RenTech | quant | 302.4K | $1.12M | 0.00% | Added+37.2% | 2026-03-31 |
| StateStreet | passive | 120.2K | $443.56K | 0.00% | Added+3.0% | 2026-03-31 |
| Citadel | multi-strat | 34.8K | $128.33K | 0.00% | Added+56.7% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-06upcoming | -0.09 | — | — |
| 2026-05-07 | -0.11 | -0.05 | +54.55% |
| 2026-03-10 | -0.06 | -0.03 | +46.43% |
| 2025-11-06 | -0.10 | -0.05 | +51.22% |
| 2025-08-07 | -0.09 | -0.09 | +3.57% |
| 2025-05-08 | -0.12 | -0.10 | +16.67% |
| 2025-03-13 | -0.16 | -0.12 | +25.00% |
| 2024-11-08 | -0.19 | -0.14 | +25.00% |
| 2024-08-08 | -0.19 | -0.19 | +1.72% |
| 2024-05-09 | -0.19 | -0.22 | -13.80% |
| 2024-03-21 | -0.21 | -0.19 | +12.48% |
| 2023-11-09 | -0.11 | -0.13 | -21.87% |
| 2023-08-10 | -0.09 | -0.11 | -14.11% |
| 2023-05-11 | -0.14 | -0.10 | +28.57% |
| 2023-03-16 | -0.14 | -0.17 | -21.43% |
| 2022-11-10 | -0.14 | -0.17 | -21.43% |